新发性心力衰竭与减少喷射分数管理:单一中心,现实生活的突尼斯经验
Meriem Drissa1, Marouan Krid2, Fares Azaiez2
1Cardiology Department, La Rabta University Hospital Tunis, Tunis, Tunisia. meriemdrissa@yahoo.fr.
概括
这项关于突尼斯心力衰竭的研究发现,尽管缺血性心脏病是主要原因,但患者管理往往未达到国际标准,这表明需要改进护理策略.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 心力衰竭 (HF) 是一个重要的公共卫生问题,在突尼斯的数据有限.
- 新发性HF与左心室喷射分数 (HFrEF) 减少需要详细的流行病学和临床表征.
- 根据国际建议评估管理实践对于改善患者的治疗结果至关重要.
研究的目的:
- 确定突尼斯新发性HFrEF的流行病学,临床,治疗和预后特征.
- 评估高频管理是否遵守国际准则.
- 确定突尼斯医疗保健系统内需要改善的HF护理领域.
主要方法:
- 一项涉及210名被诊断患有新发性HFrEF的患者的研究.
- 收集有关患者人口统计,病因,左心室喷射率 (LVEF) 和处方治疗的数据.
- 对住院和1年死亡率和再住院率的分析.
主要成果:
- 患者的平均年龄为64岁,男性占主导地位 (性别比2.8).
- 缺血性心脏病是主要病因 (46.2%),平均LVEF为33%.
- 观察到低于最佳指导方针的医疗治疗,只有35.7%接受三重治疗和8.1%接受四重治疗. 医院死亡率为3.8%,一年死亡率为18.1%,再住院率为42.2%.
结论:
- 该研究揭示了突尼斯HFrEF的独特流行病学和临床特征.
- 与国际标准相比,当前的患者管理存在缺陷.
- 建议建立一个国家高频率注册表,以进行更强大的数据分析和明智的临床实践改进.
相关概念视频
Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure IV: Classification and Diagnostic Evaluation
17
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
17
Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Mitral Regurgitation IV: Nursing Management
40
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
40


